SRX sierra rutile holdings limited

Moreover, BTG has a very limited indication for its theraspheres...

  1. 8,918 Posts.
    lightbulb Created with Sketch. 32
    Moreover, BTG has a very limited indication for its theraspheres ... again IF SRX reports good results from HCC trials it can petition FDA to revoke BTG indication.

    Correct. Thera has a HDE which means it can only be marketed as there is no other likewise therapy. If SRX get an FDA approval to market for HCC, the HDE can be challenged very quickly.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.